• Causative genes for ARVC and their respective characteristic

  2019-05-22

  

  Causative genes for ARVC and their respective characteristics are summarized in Table 1. Desmosome genes for ARVC Other causative genes for ARVC Although more than half of ARVC patients carry mutations in desmosome genes, other genes have also been reported as causative genes for ARVC (Table

• br Results and discussion br Authorship contributions br Con

  2019-05-22

  

  Results and discussion Authorship contributions Conflict of interest Acknowledgments This work is supported by grants from the United States National Institutes of Health/National Cancer Institute: R01 CA098472 and R01 CA170334. We thank Dr. Dan Zhang and Andy Awwad for technical assista

• Despite a substantial reduction in global maternal

  2019-05-22

  

  Despite a substantial reduction in global maternal deaths due to postpartum haemorrhage between 1990 and 2013 (from 71 295 to 44 190), this condition continues to be the main cause of maternal mortality worldwide. In sub-Saharan Africa and south Asia, many women still deliver at home without a skill

• br Methods This was a retrospective review of hospital recor

  2019-05-22

  

  Methods This was a retrospective review of hospital records of dental patients who were treated under GA from January 2006 until November 2015. All participants who attended our hospital were first examined to evaluate their behavioral capabilities and their psychological and physical disabilitie

• br Conclusion br Conflict of interest

  2019-05-22

  

  Conclusion Conflict of interest Introduction The implantable cardioverter-defibrillator (ICD) has dramatically reduced the risk of sudden death in patients with malignant ventricular tachyarrhythmias [1,2]. However, 10–30% of patients who have undergone ICD implantation experience “electric

• For the relationship between the PVAB

  2019-05-22

  

  For the relationship between the PVAB and FFRWs, setting the PVAB period as short as possible is considered optimal, because not all patients necessarily have problems with FFRWs [4,6]. However, the Medtronic pacemakers investigated in this study had minimum PVAB values as short as 110ms or 130ms, w

• br Results br Discussion We identified

  2019-05-22

  

  Results Discussion We identified a novel, heterozygous nonsense SCN5A mutation, Q779X, in a family with overlapped phenotype with progressive conduction defects and BrS. The proband suffered from SSS at the age of three, and subsequent ventricular fibrillation with a coved type Brugada ECG pat

• Vuelve a aparecer aqu la

  2019-05-22

  

  Vuelve Lenalidomide aparecer aquí la íntima satisfacción de un Aub cuyas obras, por expeditivas que sean —dos semanas para elaborar toda una exposición— y mediocres que puedan parecer, levantan pasiones entre los entendidos en arte porque en buena medida es a ellos, capaces de mutar la arena en oro

• Cuando Gonzalo Pizarro se alz en

  2019-05-21

  

  Cuando Gonzalo Pizarro se alzó en el Perú, nunca mostró intenciones de romper los vínculos que lo unían p2x receptors su rey, por mucho que su plan fuese establecer una monarquía, autónoma de la castellana, que gobernaría el territorio. En las misivas que envió al monarca, Pizarro confirmaba su obed

• Dig-11-utp Supplier After exclusion of secondary causes of e

  2019-05-21

  

  After exclusion of secondary causes of eosinophilia, diagnostic evaluation of primary eosinophilias relies on a combination of morphologic review of the blood and marrow, standard cytogenetics, fluorescent in situ hybridization, flow immunocytometry, and T-cell clonality assessment to detect histopa

• AP1903 La descripci n de la batalla de Churubusco

  2019-05-21

  

  La descripción de la batalla de Churubusco obtiene un grado mayor de dramatismo en el tiempo presente, índice de un tiempo congelado, eternizado en un momento histórico, aunque no en sitio sino desde el punto de vista de Juan Bolao (“que subía al mirador”) desde la Quinta de San Jacinto, lugar campe

• Repurposing use of approved drugs for

  2019-05-21

  

  Repurposing (use of approved drugs for new indications) or repositioning (use of drugs whose development was not continued for new indications) of existing drugs has been put forward as a method to overcome some of these issues. Indeed, drug repositioning and repurposing could lead to higher rates o

• 4-ethylphenyl sulfate manufacturer Hablar del movimiento pos

  2019-05-21

  

  Hablar del movimiento posmoderno parece haberse convertido en un lugar común. Un movimiento artístico, cultural o filosófico que se escape 4-ethylphenyl sulfate manufacturer las expectativas de lo preestablecido suele denominarse rápidamente “posmoderno” sin indagar con profundidad cuáles son las ca

• Methods The FMSTP accepts Basotho doctors after they

  2019-05-21

  

  Methods The FMSTP accepts Basotho doctors after they AS1404 manufacturer have completed medical school and at least 1 year of internship. The first 2 years of the 4 year programme are focused most intensely on clinical training, with registrars working very closely with faculty trainers at their di

• What can be done to reduce morbidity and mortality

  2019-05-21

  

  What can be done to reduce morbidity and mortality in HEU infants? Notably, a third of all mortality in the Botswana trial occurred early, before randomisation. Similarly, in a trial of more than 14 110 infants in Zimbabwe, done in the pre-MTCT-prevention era, HIV-exposed uninfected infants had 50%

15412 records 1011/1028 page Previous Next First page 上5页 10111012101310141015 下5页 Last page